118th Congress (2023–2025) · House bill · Sponsor: Rep. Wexton, Jennifer [D-VA-10]
This page covers HR3391 in the 118th Congress. Bill numbers start over every Congress, so HR3391 in another Congress is a different bill.
| Item | Detail |
|---|---|
| Roll-call votes | 1 |
| Chamber | House |
| Latest vote | 2024-03-05: Passed |
| Latest action | 2025-01-04: Became Public Law No: 118-228. |
| Policy area | Health |
| Official record | Congress.gov |
Gabriella Miller Kids First Research Act 2.0This act reauthorizes through FY2028 a pediatric disease research initiative within the National Institutes of Health (NIH) and requires the NIH to coordinate pediatric research activities to avoid duplicative efforts. Additionally, the Department of Health and Human Services must report to Congress about research funded through the initiative.
Subjects: Banking and financial institutions regulation, Cancer, Child health, Civil actions and liability, Department of Health and Human Services, Drug safety, medical device, and laboratory regulation, Government trust funds, Health programs administration and funding, Medical research, National Institutes of Health (NIH)
Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.
| Date | Chamber | Question | Result | Yea | Nay | Not voting | Record |
|---|---|---|---|---|---|---|---|
| 2024-03-05 | House | 2/3 Yea-And-Nay | Passed | 330 | 4 | 32 | Official tally |
HR3391 (Gabriella Miller Kids First Research Act 2.0) was introduced in the 118th Congress (2023–2025) by Rep. Wexton, Jennifer [D-VA-10].
On 2025-01-04: Became Public Law No: 118-228.
1 recorded vote in the 118th Congress. The most recent, on 2024-03-05, was "2/3 Yea-And-Nay": Passed.